author-photo

Angelo J. Trapani

Novartis

39

Papers

1914

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

MO136RELATIONSHIP BETWEEN UPCR AND EGFR IN C3 GLOMERULOPATHY

2021 Nephrology Dialysis Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Correlation With Outcomes

2013 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (357)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

2013 The Lancet
Show All
- Source
- Cite
- Save
Citations (744)
The Effects of Aldosterone Synthase Inhibition on Aldosterone and Cortisol in Patients With Hypertension: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Study

2012 Journal of Clinical Hypertension
Show All
- Source
- Cite
- Save
Citations (37)
The RELAXin in Acute Heart Failure (RELAX-AHF) Trial

2012 Circulation
Show All
- Source
- Cite
- Save
Citations (0)
Response to Letter to Regarding Article, “Effects of Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial”

2012 Circulation
Show All
- Source
- Cite
- Save
Citations (0)
Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary HypertensionClinical Perspective: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial

2011 Circulation
Show All
- Source
- Cite
- Save
Citations (0)
Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension

2011 Circulation
Show All
- Source
- Cite
- Save
Citations (4)
BLOCKADE OF ALDOSTERONE PRODUCTION AS A NOVEL APPROACH TO THE MANAGEMENT OF HIGH BLOOD PRESSURE: EFFICACY AND TOLERABILITY OF THE ALDOSTERONE SYNTHASE INHIBITOR LCI699 IN PATIENTS WITH STAGE 1-2 HYPERTENSION

2010 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (9)
CGS 30440: A dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11

2006 Cardiovascular Drug Reviews
Show All
- Source
- Cite
- Save
Citations (10)